Zobrazeno 1 - 10
of 60
pro vyhledávání: '"V V Troitskaya"'
Autor:
A V Bazhenov, G M Galstyan, E N Parovichnikova, V V Troitskaya, L A Kuzmina, Z T Fidarova, E O Gribanova, S A Makhinya, O A Latyshkevich, U A Chabaeva, S M Kulikov, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 91, Iss 7, Pp 14-24 (2019)
Aim. Remission induction can be associate, with the life threatening complications and transfer to ICU of de novo acute myeloid leukemia (AML) patients (pts). We evaluate influence of transfer to ICU and life threatening complication on early mortali
Externí odkaz:
https://doaj.org/article/0f9fa6f9da044e4fb6fbb3950117b512
Autor:
E N PAROVICHNIKOVA, I A LOUKIANOVA, V V TROITSKAYA, M Y DROKOV, T I LOBAOVA, L A KUZMINA, A N SOKOLOV, A V KOKHNO, Z T FIDAROVA, G A BASKHAEVA, O A GAVRILINA, V A VASILYEVA, T N OBUKHOVA, S A KUZNETSOVA, A B SUDARIKOV, V N DVIRNIK, I V GALTSEVA, J O DAVIDIVA, S M KULIKOV, V G SAVCHENKO
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 14-22 (2018)
Objective. To analyze treatment results of 172 patients with acute myeloid leukemia (AML) aged 18-60 years in National Medical Research Center for Hematology of MHRF. Materials and methods. Inductive and consolidation program for 139 (80%) patients w
Externí odkaz:
https://doaj.org/article/86c14a4b80d349a59c1c8acc0003408d
Autor:
I S PISKUNOVA, T N OBUKHOVA, E N PAROVICHNIKOVA, S M KULIKOV, V V TROITSKAYA, O A GAVRILINA, V G SAVCHENKO
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 30-37 (2018)
Objective. To evaluate occurrence, variety, structural peculiarities and prognostic meaning of cytogenetic abnormalities in adult patients with Ph-negative acute lymphoblastic leukemia (ALL) receiving therapy according to ALL-2009 protocol. Materials
Externí odkaz:
https://doaj.org/article/6e9562f2a9784fcc94b28e7c5c187b4d
Autor:
K I ZARUBINA, E N PAROVICHNIKOVA, G A BASKHAEVA, A E KRASILNIKOVA, O A GAVRILINA, B V BIDERMAN, A B SUDARIKOV, S N BONDARENKO, Y O DAVYDOVA, I V GALTSEVA, A N SOKOLOV, V V TROITSKAYA, V G SAVCHENKO
Publikováno v:
Терапевтический архив, Vol 90, Iss 7, Pp 110-117 (2018)
B-cell acute lymphoblastic leukemia (B-ALL) is a diverse group of malignant blood disorders both with regard to the biological properties of the tumor and to therapeutic approaches. Immunophenotyping, molecular genetic techniques, whole-genome sequen
Externí odkaz:
https://doaj.org/article/c3265da0ddc142569d2dbeb8caaa9524
Autor:
E N Ignatova, T A Tupoleva, E N Ovchinnikova, T Yu Romanova, N G Yaroslavtseva, F P Filatov, V V Troitskaya, L A Kuzmina, E N Parovichnikova, T V Gaponova, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 89, Iss 11, Pp 27-34 (2017)
Aim. To evaluate the detection rate of markers for hepatitis B virus (HBV) in the blood samples taken from patients with blood system diseases, by applying the current approaches to examining donated blood and its components for markers of viral infe
Externí odkaz:
https://doaj.org/article/1c6b5ee88fd642328a3e68ecd712fa73
Autor:
O A Gavrilina, V V Troitskaya, E E Zvonkov, E N Parovichnikova, G M Galstyan, L S Biryukova, I V Nesterenko, A M Kovrigina, A V Bazhenov, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 89, Iss 7, Pp 69-75 (2017)
Primary central nervous system (CNS) lymphomas account for 13-20% of the posttransplant lymphoproliferative disorders (PTLD) and rank among the most aggressive conditions. Reduction of immunosuppressive therapy should be mandatory to treat PTLD, but
Externí odkaz:
https://doaj.org/article/42f6c3caa4f847508d481d69f8149fae
Autor:
I V Galtseva, Yu O Davydova, T V Gaponova, N M Kapranov, L A Kuzmina, V V Troitskaya, E O Gribanova, S K Kravchenko, Ya K Mangasarova, E E Zvonkov, E N Parovichnikova, L P Mendeleeva, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 89, Iss 7, Pp 18-24 (2017)
Aim. To identify a parameter predicting a collection of at least 2·106 CD34+ hematopoietic stem cells (HSC)/kg body weight per leukapheresis (LA) procedure. Subjects and methods. The investigation included 189 patients with hematological malignancie
Externí odkaz:
https://doaj.org/article/a3f6e2769d9a40449b2d43a5a05d91df
Autor:
E N Parovichnikova, V V Troitskaya, A N Sokolov, S N Bondarenko, O A Gavrilina, G A Baskhaeva, B V Biderman, I A Lukyanova, L A Kuz'mina, G A Klyasova, S K Kravchenko, E O Gribanova, E E Zvonkov, Z Kh Akhmerzaeva, O Yu Baranova, T S Kaporskaya, T V Ryltsova, E N Zotina, E E Zinina, O S Samoilova, K D Kaplanov, L V Gavrilova, T S Konstantinova, V A Lapin, A S Pristupa, A S Eluferyeva, T N Obukhova, I S Piskunova, I V Gal'tseva, V N Dvirnyk, M A Rusinov, S M Kulikov, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 89, Iss 7, Pp 10-17 (2017)
Aim. To analyze the efficiency and reproducibility of the ALL-2009 protocol within the Russian prospective multicenter study based on different principles of cytostatic effects (non-intensive, but continuous cytotoxic treatment and a small number of
Externí odkaz:
https://doaj.org/article/70eebaa576c444a0a015d4c4e514ab53
Autor:
A. V. Abramova, E. A. Mikhailova, I. V. Galtseva, Z. T. Fidarova, A. V. Luchkin, N. M. Kapranov, Yu. O. Davydova, S. M. Kulikov, V. V. Troitskaya, E. N. Parovichnikova
Publikováno v:
Онкогематология, Vol 19, Iss 3, Pp 159-172 (2024)
Background. Aplastic anemia (AA) is a non-tumor and rare disease of the blood system, characterized by deep pancytopenia due to the development of bone marrow aplasia with immune-mediated damage of hematopoietic stem cells. Research results indicate
Externí odkaz:
https://doaj.org/article/6ae7e02ccac14db383e9da874da659fb
Autor:
E N Parovichnikova, A N Sokolov, V V Troitskaya, G A Klyasova, M A Rusinov, Z Kh Akhmerzaeva, L A Kuzmina, S N Bondarenko, O Yu Baranova, T S Kaporskaya, E N Zotina, E E Zinina, O S Samoilova, L V Gavrilova, K D Kaplanov, T S Konstantinova, V A Lapin, S K Kravchenko, E O Gribanova, E E Zvonkov, O A Gavrilina, G A Baskhaeva, G M Galstyan, T N Obukhova, I V Galtseva, S M Kulikov, V G Savchenko
Publikováno v:
Терапевтический архив, Vol 88, Iss 7, Pp 15-24 (2016)
Aim. To analyze well-known risk factors (RFs), such as age, immunophenotype, baseline leukocytosis, enhanced lactate dehydrogenase (LDH) activity, time to achieve complete remission, a risk group, and cytogenetic abnormalities) in patients with acute
Externí odkaz:
https://doaj.org/article/b71326aeda7841e4b4714c86f887ce4f